Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
35.9M
-
Shares change
-
+35.9M
-
Total reported value, excl. options
-
$776M
-
Value change
-
+$776M
-
Number of buys
-
71
-
Price
-
$21.67
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q1 2019
71 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q1 2019.
Gossamer Bio, Inc. - Common Stock (GOSS) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.9M shares
of 227M outstanding shares and own 15.79% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (6.95M shares), HILLHOUSE CAPITAL MANAGEMENT, LTD. (4.97M shares), Capital International Investors (3.28M shares), BOXER CAPITAL, LLC (1.88M shares), Artal Group S.A. (1.66M shares), ALLIANCEBERNSTEIN L.P. (1.39M shares), VANGUARD GROUP INC (1.37M shares), BAUPOST GROUP LLC/MA (1.27M shares), FMR LLC (1.23M shares), and CITADEL ADVISORS LLC (973K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.